AGSP 1217

Study Name
AGSP 1217
Clinical Trial Category (check all that apply)
  • Beyond First Line Therapy
  • Targeted Therapy
Study Center
Institution Name
Cleveland Clinic
Institution Address
9500 Euclid Avenue
City
Cleveland
State
Ohio
Zip Code
44195
Study Contacts
Principal Investigator
Dr.Davendra Sohal
P.I. Phone
(216) 444-8258
P.I. Email
sohald@ccf.org
Study Coordinator
Madeleine Kaczmarowski,
Study Coordinator Phone
(216) 636-5644
Study Coordinator Email
KACZMAM1@ccf.org
OVERVIEW – in layman’s terms (150 words max)
A clinical trial to study AG-120 in previously treated patients with non-resectable or metastatic cholangiocarcinoma with an IDH1 mutation.
Enrollment
0
Study Start Date
10/10/2017
Estimated Completion Date
05/08/2017
Translate »

Pin It on Pinterest